ConsumerDaily Briefs

Daily Brief Consumer: Alibaba Health Information Tec, Shandong Fengxiang, Anjoy Foods Group, Puregold Price Club, Boxihe Outdoor Sports Group, Cosmecca Korea , Wakefit Innovations, MAP Aktif Adiperkasa PT, China Travel International Investment Hong Kong, Perfect Medical Health and more

In today’s briefing:

  • Alibaba Health Placement – Delta Placement for EB, but Track Record Isn’t Great
  • Fengxiang (9977 HK): Precondition Satisfied
  • Anjoy Foods Group A/H Trading – Cheap Price but Sluggish Demand
  • Puregold Price Club (PGOLD PM) – Members Bring Benefits
  • Boxihe Outdoor Sports Pre-IPO – Scaling Fast in China’s Outdoor Boom
  • Cosmecca Korea: Switching Listing from KOSDAQ to KOSPI Likely to Be Completed in 2H 2025
  • Wakefit Innovations Ltd Pre-IPO Tearsheet
  • MAP Aktif (MAPA IJ) — 2025 Update
  • China Travel Intl Inv (308 HK): What’s UP?
  • Perfect Medical (1830 HK): Green Shoots Emerging After A Disastrous FY25


Alibaba Health Placement – Delta Placement for EB, but Track Record Isn’t Great

By Sumeet Singh

  • Banks are offering US$500m of Alibaba Health Information Tec (241 HK) stock in order to allow Exchangeable Bond investors to hedge their exposure.
  • Alibaba Health (AH) stock has been heading in the wrong direction for the past few years and it remains unclear if the EB offering was well flagged.
  • In this note, we will talk about the deal dynamics and run the deal through our ECM framework.

Fengxiang (9977 HK): Precondition Satisfied

By Arun George

  • The precondition for the PAG privatisation offer for Shandong Fengxiang (9977 HK) is satisfied. The composite document will be despatched by 11 July. 
  • Despite being a 39.9% discount to the IPO price, the offer is attractive compared to precedent transactions and peer multiples. 
  • The scheme vote remains low-risk due to the irrevocables, the lack of protest votes at the recent AGM, and the signalling from PAG’s decision not to introduce a scrip offer. 

Anjoy Foods Group A/H Trading – Cheap Price but Sluggish Demand

By Sumeet Singh

  • Anjoy Foods Group (2648 HK), a quick-frozen food company in China,  raised around US$350m in its H-share listing.
  • AFG was the largest quick-frozen food company in China in terms of revenue in 2023, with a market share of 6.2%, according to the Frost & Sullivan report.
  • We have looked at the past performance and likely A/H premium in our previous note. In this note, we talk about the trading dynamics.

Puregold Price Club (PGOLD PM) – Members Bring Benefits

By Angus Mackintosh

  • Puregold Price Club (PGOLD PM) is now the largest groceries company by market share in the Philippines, recently overtaking SM Retail, through its Puregold and S&R Warehouse stores. 
  • The company’s S&R Warehouse is a members-only big box retailer aiming at more affluent consumers, whilst Puregold stores cater for both Sari Sari (mom&pop) and less affluent consumers. 
  • Puregold Price Club booked a solid start to the year, despite seasonal disruptions, with management remaining confident about the outlook for FY2025. Valuations are attractive. 

Boxihe Outdoor Sports Pre-IPO – Scaling Fast in China’s Outdoor Boom

By Troy Wong

  • Boxihe Outdoor Sports (BOS) is looking to raise at least US$100m in its upcoming Hong Kong IPO.
  • BOS has delivered impressive growth, with a 122% revenue CAGR (FY22–24) led by its core Pelliot brand.
  • Its shift from a pure online DTC model to include offline and distributor channels has broadened reach, while improving gross margins reflect strong pricing and cost control.

Cosmecca Korea: Switching Listing from KOSDAQ to KOSPI Likely to Be Completed in 2H 2025

By Douglas Kim

  • On 2 July, Cosmecca Korea (241710 KS) announced that it plans to switch its listing from KOSDAQ to KOSPI. Cosmecca Korea is the third largest cosmetics ODM company in Korea.
  • Cosmecca Korea’s ROE is similar to the average ROE of the comps. However, Cosmecca Korea’s P/B valuation is 36% discount to that of the comps.
  • By switching its listing from KOSDAQ to KOSPI, there is an increasing probability of the Cosmecca Korea receiving higher valuations, narrowing the gap with its peers. 

Wakefit Innovations Ltd Pre-IPO Tearsheet

By Rosita Fernandes

  • Wakefit Innovations (1684049D IN)  (WIL)  is looking to raise about US$231m in its upcoming India IPO. The bookrunners for the deal are Axis, IIFL, Nomura.
  • Wakefit Innovations is direct‑to‑consumer and sleep and home‑solutions company, founded in 2016.
  • According to the Redseer Report, the company was the largest D2C home and furnishings company in India by revenue in FY24.

MAP Aktif (MAPA IJ) — 2025 Update

By Michael Fritzell

  • MAP Aktif is the sportswear subsidiary of Indonesian retail giant Mitra Adiperkasa.

  • I wrote a deep dive on MAP Aktif in January 2022, during the depths of the COVID-19 pandemic.

  • At the time, it was suffering from Indonesia’s large-scale social distancing restrictions. But I thought that it would eventually recover, continue growing its store count, and end up with a single-digit P/E ratio.


China Travel Intl Inv (308 HK): What’s UP?

By Osbert Tang, CFA

  • China Travel International Investment Hong Kong (308 HK)‘s 1-week share price rally was driven by restructuring speculations. Yet, underlying operations have improved in 2H24.  
  • Tourist attractions and hotel operations will stay decent in FY25, and more projects will come on stream to fuel profitability.
  • Asset-Based valuation should be the focus, and its 0.49x P/B is inexpensive. Net cash now equals 8.2% of the share price. 

Perfect Medical (1830 HK): Green Shoots Emerging After A Disastrous FY25

By Sameer Taneja

  • Perfect Medical Health (1830 HK) reported a disastrous FY25 with revenues/profits down 19.1%/34.5% YoY. For H2 FY25, revenues/profits were down 25%/48% YoY. 
  • The company saw a stabilization in its revenues QoQ for H2 FY25, and is now seeing a slight uptick in revenues/profits courtesy of revamped stores ramping up and cost-cutting measures.  
  • With 23% of its market cap in cash/investments, a PE of 10.4x/8.0x for FY25/FY26e, respectively, the company has an appetizing dividend yield of 12.5% (assuming -4.5% YoY revenue growth). 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars